Pravastatin suppresses the interleukin-8 production induced by thrombin in human aortic endothelial cells cultured with high glucose by inhibiting the p44/42 mitogen activated protein kinase

British Journal of Pharmacology

Volumn 134, Issue 4, 2001, Pages 753-762

  Takata, M ^a   Urakaze, M ^a   Temaru, R ^a   Yamazaki, K ^a   Nakamura, N ^a   Nobata, Y ^a   Kishida, M ^a   Sato, A ^a   Kobayashi, M ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Diabetic macroangiopathy; Endothelium; Interleukin 8; MAP kinase; Pravastatin; Signal transduction; Thrombin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 8; PRAVASTATIN; THROMBIN;

ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; DIABETIC ANGIOPATHY; DRUG EFFECT; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0034748052     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704305     Document Type: Article

References (44)

1. Thrombin activates nuclear factor-kappaB and potentiates endothelial cell activation by TNF
2. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice
3. Potent and specific inhibition of IL-8-, IL-1 alpha- and IL-1 beta-induced in vitro human lymphocyte migration by calcium channel antagonists
4. Increased prothrombin fragment 1+2 in type I diabetic patients
5. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
6. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins
7. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
8. Regulation of the mevalonate pathway
9. Cooling and rewarming-induced IL-8 expression in human bronchial epithelial cells through p38 MAP kinase-dependent pathway
10. Endothelial cell tyrosine kinase receptor and G protein-coupled receptor activation involves distinct protein kinase C isoforms
11. All ras proteins are polyisoprenylated but only some are palmitoylated
12. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin- 1 and endothelial nitric oxide synthase in vascular endothelial cells
13. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation
14. Fibrinopeptide-A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance, and hemodynamic changes
15. Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-alpha-independent IL-8 secretion and E-selectin expression
16. Mechanical stretch activates a pathway linked to mevalonate metabolism in cultured neonatal rat heart cells
17. Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus
18. Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms
19. Posttranslational modification of proteins by isoprenoids in mammalian cells
20. Interleukin-8 and MCAF: Novel leukocyte recruitment and activating cytokines
21. Activation of Ras by phorbol esters in cardiac myocytes. Role of guanine nucleotide exchange factors
22. Inhibition of human vascular smooth muscle cell proliferation by lovastatin: The role of isoprenoid intermediates of cholesterol synthesis
23. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types
24. Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells
25. Reduction of stroke incidence after myocardial infarction with pravastatin: The Cholesterol and Recurrent Events (CARE) study
26. Atherosclerosis-an inflammatory disease
27. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall
28. Lovastatin induces apoptosis in malignant mesothelioma cells
29. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators
30. Cross-linking of intercellular adhesion molecule-1 induces interleukin-8 and RANTES production through the activation of MAP kinases in human vascular endothelial cells
31. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
32. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
33. Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells
34. Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC
35. High glucose enhances the gene expression of interleukin-8 in human endothelial cells, but not in smooth muscle cells: Possible role of interleukin-8 in diabetic macroangiopathy
36. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
37. Thrombin stimulates production of interleukin-8 in human umbilical vein endothelial cells
38. The IL-8 production in endothelial cells is stimulated by high glucose
39. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma
40. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
41. Inhibition of MAP kinase kinase (MEK) blocks endothelial PGI2 release but has no effect on von Willebrand factor secretion or E-selectin expression
42. Interleukin-8 is chemotactic for vascular smooth muscle cells
43. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells
44. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1